Search / Trial NCT06222814

Evaluation of the Results of Two Different Methods in Management of Antero-lateral Instability of the Knee

Launched by SOHAG UNIVERSITY · Jan 24, 2024

Trial Information

Current as of October 04, 2024

Recruiting

Keywords

Description

Patients will undergo an anatomic ACLR in a standardized fashion by the same team of surgeons. They are randomly divided into 2 groups either ACLR plus ALL reconstruction or ACLR combined with LET in a 1:1 ratio. There are multiple graft options for ACL-R, but here for the study, the hamstring autograft is harvested following the traditional technique. The graft is measured and bony tunnels are drilled. An anatomical reconstruction technique is used in all cases. In group A: the surgeon will harvest peroneus longus graft, then sutured to the double bundle hamstring graft. The graft diamete...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. The ACL deficient knee was clinically manifested by physical examination and confirmed by MRI.
  • 2. Age 18-45 years, skeletally mature patient.
  • 3. A positive pivot shift test of at least grade II is required (significant anterolateral instability).
  • Exclusion Criteria:
  • 1. Multiple ligament injuries or a polytraumatized patient
  • 2. Revision cases.
  • 3. Generalized laxity.
  • 4. Symptomatic articular cartilage defect requiring treatment; Outerbridge \> grade II.
  • 5. More than three degrees of varus or valgus malalignment

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Sohag, , Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0